Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Interest Expenses of $1.9 million for Q2 2026, up 6.36% year-over-year from $1.8 million in Q2 2025, and down 94.61% quarter-over-quarter from $34.7 million in Q1 2026.
Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Interest Expenses for 3 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Expenses rose 6.36% year-over-year to $1.9 million; the TTM figure through Apr 2026 stood at $7.3 million (down 5.26% YoY), while the FY2026 annual figure was $126.0 million, up 21.33% from the prior year.
- Interest Expenses retreated to $1.9 million in Q2 2026 per KMTS's latest filing, from $34.7 million in the prior quarter.
- Across five years, Interest Expenses topped out at $47.3 million in Q4 2025 and bottomed at -$665000.0 in Q2 2024.
- Historically, Interest Expenses has averaged $9.5 million across 3 years, with a median of $1.9 million in 2024.
- On a YoY basis, Interest Expenses climbed as much as 1943.25% in 2025 and fell as far as 2.03% in 2025.
- Kestra Medical Technologies' Interest Expenses stood at $2.3 million in 2024, then surged by 1943.25% to $47.3 million in 2025, then sank by 96.05% to $1.9 million in 2026.
- Business Quant data shows KMTS's Interest Expenses at $1.9 million in Q2 2026, $34.7 million in Q1 2026, and $47.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.87 Mn |
| Apr 30, 2026 | 1.87 Mn |
| Jan 31, 2026 | 34.73 Mn |
| Jan 31, 2026 | 34.73 Mn |
| Oct 31, 2025 | 47.34 Mn |
| Oct 31, 2025 | 47.34 Mn |
| Jul 31, 2025 | 1.91 Mn |
| Jul 31, 2025 | 1.91 Mn |
| Apr 30, 2025 | 1.76 Mn |
| Apr 30, 2025 | 1.76 Mn |
| Jan 31, 2025 | 1.78 Mn |
| Jan 31, 2025 | 1.78 Mn |
| Oct 31, 2024 | 2.32 Mn |
| Oct 31, 2024 | 2.32 Mn |
| Jul 31, 2024 | 1.87 Mn |
| Jul 31, 2024 | 1.87 Mn |
| Apr 30, 2024 | -665,000.00 |
| Apr 30, 2024 | -665,000.00 |
| Jan 31, 2024 | 1.65 Mn |
| Jan 31, 2024 | 1.65 Mn |